secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2026-10-14T20:05:14+00:00
Accession:  0001437749-26-032620
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

CervoMed posts investor presentation to website; no clinical or financial data in 8-K text
--------------------------------------------------------------------------------

- CervoMed Inc. (NASDAQ: CRVO) made an investor presentation available on www.cervomed.com under 'Investors - Events and Presentations' as of October 14, 2026.
- The 8-K states the deck covers business, clinical studies, development plans and financial position, but no specific trial results, figures or guidance are included.
- Management may use the presentation periodically in conferences, meetings and presentations to investors and analysts, with possible non-material modifications.
- Signed by William Elder, Chief Financial Officer & General Counsel; the only exhibit listed is the cover page XBRL data file.
- No substantive news: the filing text contains no numbers, trial endpoints, dates or updated guidance investors can act on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926032620/0001437749-26-032620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926032620/crvo20261014_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-032620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer